Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis

Open access

Abstract

Hepatocellular carcinoma (HCC), the fourth leading cause of cancer mortality worldwide, develops almost exclusively in patients with chronic liver disease and advanced fibrosis1,2. Here we interrogated functions of hepatic stellate cells (HSCs), the main source of liver fibroblasts3, during hepatocarcinogenesis. Genetic depletion, activation or inhibition of HSCs in mouse models of HCC revealed their overall tumour-promoting role. HSCs were enriched in the preneoplastic environment, where they closely interacted with hepatocytes and modulated hepatocarcinogenesis by regulating hepatocyte proliferation and death. Analyses of mouse and human HSC subpopulations by single-cell RNA sequencing together with genetic ablation of subpopulation-enriched mediators revealed dual functions of HSCs in hepatocarcinogenesis. Hepatocyte growth factor, enriched in quiescent and cytokine-producing HSCs, protected against hepatocyte death and HCC development. By contrast, type I collagen, enriched in activated myofibroblastic HSCs, promoted proliferation and tumour development through increased stiffness and TAZ activation in pretumoural hepatocytes and through activation of discoidin domain receptor 1 in established tumours. An increased HSC imbalance between cytokine-producing HSCs and myofibroblastic HSCs during liver disease progression was associated with increased HCC risk in patients. In summary, the dynamic shift in HSC subpopulations and their mediators during chronic liver disease is a…

Overview

Integrity signals

Registry

Crossref · 10.1038/s41586-022-05289-6

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

10 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 71 references

Research works printed but not linked: 1

  1. Affo, S. et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 39, 866–882.e11 (2021). · DOI · Paper page

Cited by

See all 384

Metadata

Authors
Filliol, A., Saito, Y., Nair, A., Dapito, D. H., Yu, L.-X., Ravichandra, A., Bhattacharjee, S., Affo, S., Fujiwara, N., Su, H., Sun, Q., Savage, T. M., Wilson-Kanamori, J. R., Caviglia, J. M., Chin, L., Chen, D., Wang, X., Caruso, S., Kang, J. K., Amin, A. D., Wallace, S., Dobie, R., Yin, D., Rodriguez-Fiallos, O. M., Yin, C., Mehal, A., Izar, B., Friedman, R. A., Wells, R. G., Pajvani, U. B., Hoshida, Y., Remotti, H. E., Arpaia, N., Zucman-Rossi, J., Karin, M., Henderson, N. C., Tabas, I., & Schwabe, R. F.
Affiliations
  • Columbia University (US)
  • Columbia University Irving Medical Center (US)
  • TUM Klinikum (DE)
  • Harold C. Simmons Comprehensive Cancer Center (US)
  • University of California San Diego (US)
  • City University of New York (US)
  • Widener University (US)
  • University of Pennsylvania (US)
  • Inserm (FR)
  • Centre for Inflammation Research (GB)
  • Shanghai Changzheng Hospital (CN)
Corresponding author
Schwabe, Robert F.
Venue
Nature
Published
2022-10-05
Volume
610
Issue
7931
Pages
356-365
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4302010968
Cited by
349
References
71
Citations by year
2026: 76 · 2025: 98 · 2024: 96 · 2023: 76 · 2022: 3
FWCI
41.87
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
Funders
  • Wellcome Trust (219542/Z/19/Z)
  • National Institutes of Health (1s10od020056-01)
  • National Cancer Institute (R01CA234128, R21CA263381, R01CA233794, R01CA190844, R01CA228483, R01CA211794, R01CA262424, R37CA258829, U01CA274295, P30CA013696)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116620, F31DK091980, R01DK128955, P30DK132710)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
hepatic stellate cells, hepatocellular carcinoma, hepatocarcinogenesis, chronic liver disease, liver fibrosis, hepatocyte growth factor, type I collagen, TAZ, DDR1, hepatocyte proliferation, hepatocyte death, extracellular matrix stiffness, single-cell RNA sequencing
MeSH terms
Discoidin Domain Receptor 1, Animals, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Hepatocyte Growth Factor, Disease Progression, Hepatocytes, Collagen Type I, Cell Proliferation, Mice, Hepatic Stellate Cells, Myofibroblasts, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. https://app.cochat.ai/papers/10.1038/s41586-022-05289-6
The paper
Filliol, A., Saito, Y., Nair, A., Dapito, D. H., Yu, L.-X., Ravichandra, A., Bhattacharjee, S., Affo, S., Fujiwara, N., Su, H., Sun, Q., Savage, T. M., Wilson-Kanamori, J. R., Caviglia, J. M., Chin, L., Chen, D., Wang, X., Caruso, S., Kang, J. K., . . . Schwabe, R. F. (2022). Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature. https://doi.org/10.1038/s41586-022-05289-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.